Skip to main navigation
Go to  Ardelyx Corporate Site
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Governance & Financials
    • Corporate Governance
    • Committee Composition
    • SEC Filings
  • Investor Resources
    • Contact IR
    • Investor FAQs
    • Email Alerts
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Governance & Financials
    • Corporate Governance
    • Committee Composition
    • SEC Filings
  • Investor Resources
    • Contact IR
    • Investor FAQs
    • Email Alerts

Press Releases

  • Apr 1, 2012
    "Non-systemic drugs: a critical review" published in Current Pharmaceutical Design
  • Aug 31, 2011
    Ardelyx, Inc. Closes $30M Series B Financing
  • Aug 31, 2011
    Ardelyx Appoints Mark Kaufmann to Chief Business Officer
  • First page «
  • Previous page ‹
  • …
  • Page 32
  • Page 33
  • Current page 34
Go to  Ardelyx Corporate Site
  • Information For

    • Medical Professionals
    • Media
    • Investors
    • Job Seekers
  • Company

    • Mission
    • Leadership Team
    • Working at Ardelyx
    • Contact Us
  • Explore

    • Patient Voices
    • Medicines
    • Publications
  • Policy

    • Terms and Conditions
    • Privacy Policy
    • Treatment Access
    • Forward-Looking Statements

© 2026 Ardelyx. All Rights Reserved.

  • Visit us on x
  • Visit us on linkedin
  • Visit us on facebook